醋酸戈舍瑞林植入剂质量回顾与分析

目的： 对近年来进口的69批次醋酸戈舍瑞林植入剂的关键质量控制项目的测定结果进行总结，同时对本品质量控制情况进行回顾和展望。方法： 对项目数据进行统计和批间趋势分析，对释放度等关键指标从实验原理、实验设计等方面加以研究。结果： 69批次样品主要项目批间趋势总体稳定，现行标准项目设置可行，对醋酸戈舍瑞林植入剂进行质量控制的总体状况较好。结论： 醋酸戈舍瑞林植入剂质量较好，总体状况稳定。本文为有效控制植入制剂质量、科学评价其安全性和有效性提供参考。

Objective: To summarize the results of the key quality control items of 69 batches of goserelin acetate sustained-release depot imported in recent years. And the quality control situation is evaluated and prospected.Methods: The determination results were subjected to statistical and quality trend analysis,and dissolution method is listed in terms of experimental principles and experimental design.Results: The trend in the 69 batches of samples is generally stable,the current standard is comprehensive and suitable for overall quality control of goserelin acetate sustained-release depot.Conclusion: The quality of goserelin acetate sustained-release depot among the batches is stable. This article provides a reference for effectively controlling the quality of implants and scientifically evaluating their safety and effectiveness. The standardization of dissolution methods and the study of the correlation between in vitro and in vivo are still difficult points for implant quality control.

[1] 中华人民共和国药典2015年版.四部通则0124[S].2015:24 ChP 2015.Vol Ⅳ.General 0124[S].2015:24
[2] USP 42 NF37[S].2019:2105
[3] BP 2019[S].2019:1196
[4] JX20010474,National Import Drug Standards(进口药品注册标准)[S].2001
[5] JX20160084,National Import Drug Standards(进口药品注册标准)[S].2016
[6] JX20180115,National Import Drug Standards(进口药品注册标准)[S].2018
[7] JX20100302,National Import Drug Standards(进口药品注册标准)[S].2010
[8] 马霄,孟丽,谭亚军,等.趋势分析在疫苗产品批签发管理中的应用[J].中国药事,2014,28(7):750 MA X,MENG L,TAN YJ,et al.Application of trend analysis method for vaccine lot release[J].Chin Pharm Aff,2014,28(7):750
[9] 崔升淼.醋酸戈舍瑞林缓释微球的制备及体外释药研究[J].中南药学,2009,7(11):801 CUI SM.Preparation and in vitro release of goserelin acetate sustained-release microspheres[J].Centr South Pharm,2009,7(11):801
[10] Srivastava A,Yadav T,Sharma S,et al.Polymers in drug delivery[J].J Biosci Med,2016,4(1):69
[11] 张伊洁,郭宁子,刘万卉,等.缓控释注射剂中丙交酯乙交酯共聚物(PLGA)分析方法的研究进展[J].中国医药工业杂志,2019,50(10):1180 ZHANG YJ,GUO NZ,LIU WH,et al.Research in analytical methods of poly(lactide-co-glycolide)(PLGA) in sustained- and controlled-release injections[J].Chin J Pharm,2019,50(10):1180
[12] QI P,BU R,ZHANG H,et al.Goserelin acetate loaded poloxamer hydrogel in plga microspheres:core-shell di-depot intramuscular sustained release delivery system[J].Mol Pharm,2019,16(8):3502
[13] SHIRANGI M,HENNINK WE,SOMSEN GW,et al.Acylation of arginine in goserelin-loaded PLGA microspheres[J].Eur J Pharm Biopharm,2016,99:18
[14] GONG F,YANG H,SUN W,et al.Development and validation of a micellar electrokinetic capillary chromatography method for the determination of goserelin and related substances[J].Electrophoresis,2016,37(4):623
[15] 张枢,韩江彬,冷广意,等.戈舍瑞林缓释植入剂在大鼠体内的药代动力学及药效动力学[J].中国药理学与毒理学杂志,2014,28(3):398 ZHANG S,HAN JB,LENG GY,et al.Pharmacokinetics and pharmacodynamics of sustained-release implant of goserelin in rats[J].Chin J Pharmacol Toxicol,2014,28(3):398
[16] KIM M K,LEE T H,SUH J H,et al.Development and validation of a liquid chromatography-tandem mass spectrometry method for the determination of goserelin in rabbit plasma[J].J Chromatogr B,2010,878(24):2235
[17] TAKYI-WILLIAMS J,ERASMUS L,HAYESHI R,et al.Development and validation of an LC-MS/MS method for the quantification of goserelin in a Pheroid? formulation,in simulated intestinal fluid[J].J Pharm Biomed Anal,2020,180:113044
[18] 王梦迪,薛英,冷广意,等.醋酸戈舍瑞林微球的体内外相关性研究[J].药学学报,2019,54(1):159 WANG MD,XUE Y,LENG GY,et al.In vitro-in vivo correlation of goserelin acetate microspheres[J].Acta Pharm Sin,2019,54(1):159
[19] 林晓鸣,郭宁子,杨化新,等.植入制剂质量控制研究进展[J].中国新药杂志,2019,28(5):528 LIN XM,GUO NZ,YANG HX,et al.Progress in quality control of implantations[J].Chin J New Drugs,2019,28(5):528
[20] 梁苑英竹,林晓鸣,刘万卉,等.肽类微球注射剂释放度实验评价研究进展[J].中国新药杂志,2017,26(24):2918 LIANG YYZ,LIN XM,LIU WH,et al.Evaluation methods of in vitro release rate of peptide microsphere injections:a review[J].Chin J New Drugs,2017,26(24):2918